ClinicalTrials.Veeva

Menu

Clinical Prognosis of Patients With Atrial Fibrillation During Radiofrequency Ablation (Isochrone-AFAn)

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Procedure: External electric cardioversion

Study type

Interventional

Funder types

Other

Identifiers

NCT03564327
NIMAO/2017-03/MG-02

Details and patient eligibility

About

Identify the parameters of the predictive isochronous map for the clinical outcome of radiofrequency ablation in terms of absence of documented atrial fibrillation recurrence at 18 months.

Enrollment

175 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is at least 18 years old
  • The patient is available for 18 month follow-up
  • The patient has paroxysmal or persistent atrial fibrillation

Exclusion criteria

  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The patient is pregnant or breastfeeding Early Study Exit Criteria: Patient does not have paroxysmal or persistent AF at the time of inclusion

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

175 participants in 1 patient group

patients with atrial fibrillation
Experimental group
Treatment:
Procedure: External electric cardioversion

Trial contacts and locations

2

Loading...

Central trial contact

Mathieu Granier, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems